Literature DB >> 21626221

Intensive hemodialysis for cardiomyopathy associated with end-stage renal disease.

Edward Nehus1, Jens Goebel, Mark Mitsnefes, Angela Lorts, Benjamin Laskin.   

Abstract

Heart and kidney dysfunction often coexist, and increasing evidence supports the interaction of these two organs, as demonstrated by the clinical condition known as cardiorenal syndrome (CRS). We report a pediatric patient with end-stage renal disease (ESRD) who developed a dilated cardiomyopathy and decompensated heart failure after undergoing unilateral nephrectomy and while on maintenance peritoneal dialysis. He showed marked improvement in his cardiac function with the addition of intensive hemodialysis. We discuss the pathophysiology of cardiorenal syndrome in patients with ESRD and suggest that intensive dialysis may be an effective therapy for this condition.

Entities:  

Mesh:

Year:  2011        PMID: 21626221     DOI: 10.1007/s00467-011-1921-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

1.  Changes in left ventricular mass in children and adolescents during chronic dialysis.

Authors:  M M Mitsnefes; S R Daniels; S M Schwartz; P Khoury; C F Strife
Journal:  Pediatr Nephrol       Date:  2001-04       Impact factor: 3.714

Review 2.  Uremia.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  N Engl J Med       Date:  2007-09-27       Impact factor: 91.245

3.  Left ventricular geometry in children with mild to moderate chronic renal insufficiency.

Authors:  Maria Chiara Matteucci; Elke Wühl; Stefano Picca; Antonio Mastrostefano; Gabriele Rinelli; Carmela Romano; Gianfranco Rizzoni; Otto Mehls; Giovanni de Simone; Franz Schaefer
Journal:  J Am Soc Nephrol       Date:  2005-11-09       Impact factor: 10.121

4.  Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis.

Authors:  Constantijn J A M Konings; Jeroen P Kooman; Marc Schonck; Ruben Dammers; Emiel Cheriex; Andrea P Palmans Meulemans; Arnold P G Hoeks; Bernardus van Kreel; Ulrich Gladziwa; Frank M van der Sande; Karel M L Leunissen
Journal:  Perit Dial Int       Date:  2002 Jul-Aug       Impact factor: 1.756

5.  Uremic cardiomyopathy--effect of hemodialysis on left ventricular function in end-stage renal failure.

Authors:  J Hung; P J Harris; R F Uren; D J Tiller; D T Kelly
Journal:  N Engl J Med       Date:  1980-03-06       Impact factor: 91.245

6.  In vitro approach to 'uremic cardiomyopathy'.

Authors:  D Weisensee; I Löw-Friedrich; M Riehle; J Bereiter-Hahn; W Schoeppe
Journal:  Nephron       Date:  1993       Impact factor: 2.847

7.  Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.

Authors:  R N Foley; P S Parfrey; J D Harnett; G M Kent; C J Martin; D C Murray; P E Barre
Journal:  Kidney Int       Date:  1995-01       Impact factor: 10.612

8.  Cardiovascular mortality in children and young adults with end-stage kidney disease.

Authors:  R S Parekh; C E Carroll; R A Wolfe; F K Port
Journal:  J Pediatr       Date:  2002-08       Impact factor: 4.406

9.  Improvement of cardiac function after haemodialysis. Quantitative evaluation by colour tissue velocity imaging.

Authors:  Shirley Yumi Hayashi; Lars-Ake Brodin; Anders Alvestrand; Britta Lind; Peter Stenvinkel; Marcelo Mazza do Nascimento; Abdul Rashid Qureshi; Samir Saha; Bengt Lindholm; Astrid Seeberger
Journal:  Nephrol Dial Transplant       Date:  2004-03-19       Impact factor: 5.992

10.  Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong.

Authors:  Claudio Ronco; Andrew A House; Mikko Haapio
Journal:  Intensive Care Med       Date:  2008-02-05       Impact factor: 17.440

View more
  1 in total

1.  Kidney transplantation in children with decreased left ventricular systolic function: a Midwest Pediatric Nephrology Consortium study.

Authors:  Sandeep K Riar; Mark M Mitsnefes; Edward J Nehus; Hiren P Patel; Julia M Steinke; Teri Crumb; Elizabeth C Abraham; Margret W Kamel; Larry A Greenbaum
Journal:  Pediatr Nephrol       Date:  2015-03-08       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.